The invalidation of Myriad Genetics' patents related to testing of the BRCA1 and BRCA2 genes in Federal Court is no laughing matter for those on either side of the issue. Nevertheless, Stephen Colbert's take on this is worth a look!
| The Colbert Report | Mon - Thurs 11:30pm / 10:30c | |||
| Formula 01 Liquid Genetic Material | ||||
|
||||
For those interested in a more serious take on the issue, an excellent PBS NewHour clip on the invalidations of Myriad's breast cancer gene patents can be found here.
Update (April 26, 2010): This Friday, April 30, Genetic Alliance will be presenting a very interesting webinar titled "The Myriad Gene Patent Case - What Does it Mean, and Why Does it Matter?"
_____
Know someone with Hereditary Breast and Ovarian Cancer risk due to a BRCA1 or BRCA2 mutation? Encourage them to check out BRCAscoop.com - a new high quality health information resource focused on newly published evidence related to cancer prevention, screening and treatment for people with BRCA1 or BRCA2 mutations
Comments